Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07272863Not ApplicableNot Yet Recruiting

The Impact of Brief Behavioral Treatment for Insomnia Versus Brief Mindfulness Treatment on Cognition and Sleep Health in Adults (Age 50+) With HIV

Role: collaborator

NCT02119702Completed

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

Role: collaborator

NCT03279185Completed

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Role: collaborator

NCT01310023Completed

Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

Role: collaborator

NCT01418014Completed

Adolescent Master Protocol

Role: collaborator

NCT05540171Not ApplicableCompleted

An Educational Intervention Program to Improve the Oral Health of HIV-Positive Children in Kano, Nigeria.

Role: collaborator

NCT02964169Not ApplicableCompleted

Family Planning and HIV in Postpartum Women in Mbarara

Role: collaborator

NCT04531072Phase 4Completed

Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine

Role: collaborator

NCT00331448Unknown

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Role: collaborator

All 9 trials loaded